相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
Issa Sadeghian et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Current and future direction in treatment of HPV-related cervical disease
Niloofar Khairkhah et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2022)
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
Karim M. Aloul et al.
FRONTIERS IN IMMUNOLOGY (2022)
Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
Misganaw Asmamaw Mengstie
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
Niloofar Khairkhah et al.
PLOS ONE (2022)
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Xin-Zhu Chen et al.
FRONTIERS IN PHARMACOLOGY (2022)
CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
Aishwarya Rajan et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2022)
Targeting RLIP with CRISPR/Cas9 controls tumor growth
Jyotsana Singhal et al.
CARCINOGENESIS (2021)
Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation
Lourdes Gutierrez-Xicotencatl et al.
MOLECULAR CANCER RESEARCH (2021)
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
Francesca Paolini et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice
Luqman Jubair et al.
PLOS ONE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
CRISPR-cas9 genome editing delivery systems for targeted cancer therapy
Asma Ghaemi et al.
LIFE SCIENCES (2021)
Epidemiology of HPV Related Malignancies
Nicholas Scott-Wittenborn et al.
SEMINARS IN RADIATION ONCOLOGY (2021)
Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells
Han Ki Lee et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis
Luigi Santacroce et al.
VIRUSES-BASEL (2021)
Analysis of NHEJ-Based DNA Repair after CRISPR-Mediated DNA Cleavage
Beomjong Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis
C. Marchetti et al.
CANCER TREATMENT REVIEWS (2020)
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal et al.
FRONTIERS IN MICROBIOLOGY (2020)
Successful delivery of large-size CRISPR/Cas9 vectors in hard-to-transfect human cells using small plasmids
Jonas Norskov Sondergaard et al.
COMMUNICATIONS BIOLOGY (2020)
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers
Shuling Ren et al.
ONCOGENE (2020)
Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?
Razmik Mirzayans et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Which Factors Affect the Occurrence of Off-Target Effects Caused by the Use of CRISPR/Cas: A Systematic Review in Plants
Dominik Modrzejewski et al.
FRONTIERS IN PLANT SCIENCE (2020)
Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus
Alejandro Moreno-Angarita et al.
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2020)
Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy
Diogo Estevao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
Kornel Labun et al.
NUCLEIC ACIDS RESEARCH (2019)
Delivery of CRISPR/Cas9 for therapeutic genome editing
Xiaojie Xu et al.
JOURNAL OF GENE MEDICINE (2019)
Presence of HPV DNA in extracellular vesicles from HeLa cells and cervical samples
Minerva Mata-Rocha et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2019)
Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors
Luqman Jubair et al.
MOLECULAR THERAPY (2019)
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
Ling Li et al.
BIOMATERIALS (2018)
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Jean-Paul Concordet et al.
NUCLEIC ACIDS RESEARCH (2018)
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Antonio Carlos de Freitas et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Virus Infection and Death Receptor-Mediated Apoptosis
Xingchen Zhou et al.
VIRUSES-BASEL (2017)
Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments
Amir Mehdi Ansari et al.
STEM CELL REVIEWS AND REPORTS (2016)
Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments
Amir Mehdi Ansari et al.
STEM CELL REVIEWS AND REPORTS (2016)
C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination
Li-Li Li et al.
PLOS ONE (2016)
CPP-Assisted Intracellular Drug Delivery, What Is Next?
Junxiao Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Novel endosomolytic peptides for enhancing gene delivery in nanoparticles
Aqeel Ahmad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses
Shweta Tripathi et al.
PLOS ONE (2015)
The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
Kengo Kuroda et al.
FRONTIERS IN ONCOLOGY (2015)
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
Shuai Zhen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
Sangsu Bae et al.
BIOINFORMATICS (2014)
E-CRISP: fast CRISPR target site identification
Florian Heigwer et al.
NATURE METHODS (2014)
Human papillomavirus oncoproteins and apoptosis (Review)
Peiyue Jiang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
Zheng Hu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Staying on target with CRISPR-Cas
Dana Carroll
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
On the selectivity and efficacy of defense peptides with respect to cancer cells
Frederick Harris et al.
MEDICINAL RESEARCH REVIEWS (2013)
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
Silke M. Currie et al.
PLOS ONE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37
Georgios Chamilos et al.
BLOOD (2012)
Design, engineering and preparation of a multi-domain fusion vector for gene delivery
Faranak Sadeghian et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Quantitative Measurement of Human Papillomavirus Type 16 E5 Oncoprotein Levels in Epithelial Cell Lines by Mass Spectrometry
Ziad Sahab et al.
JOURNAL OF VIROLOGY (2012)
Dual functions of the human antimicrobial peptide LL-37-Target membrane perturbation and host cell cargo delivery
Xuan Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications
William K. K. Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Host Defense Peptide LL-37 Activates the Tumor-suppressing Bone Morphogenetic Protein Signaling Via Inhibition of Proteasome in Gastric Cancer Cells
William Ka Kei Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth
Amanda S. Buechau et al.
JOURNAL OF IMMUNOLOGY (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer
Chi-Mu Chuang et al.
HUMAN GENE THERAPY (2009)
An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice
Georgina Paz De la Rosa et al.
VIROLOGY JOURNAL (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion
Seth B. Coffelt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors
G. Sandra Tjabringa et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37
S Tokumaru et al.
JOURNAL OF IMMUNOLOGY (2005)
The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis
S Sandgren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37
KA Henzler-Wildman et al.
BIOCHEMISTRY (2004)
The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice
D Skelton et al.
GENE THERAPY (2001)
Stability of PEI-DNA and DOTAP-DNA complexes:: effect of alkaline pH, heparin and serum
I Moret et al.
JOURNAL OF CONTROLLED RELEASE (2001)
分享论文
